Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
May 08, 2024 07:00 ET
|
Omega Therapeutics
Programmable epigenomic mRNA candidates enabled durable and robust upregulation of gene expression across a diverse set of gene types and regulatory mechanismsAdditional OMEGA platform capabilities...
Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presentations at the ASGCT Annual Meeting
May 07, 2024 08:00 ET
|
Matinas BioPharma Holdings, Inc.
BEDMINSTER, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies...
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
May 07, 2024 07:00 ET
|
Orchard Therapeutics (Europe) Limited
TOKYO, LONDON and BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around...
Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting
May 07, 2024 07:00 ET
|
Solid Biosciences Inc.
— Presentations to highlight AAV manufacturing and purification improvements, vector biology updates,and a comprehensive non-clinical data overview of the company’s lead SGT-003 program — ...
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
May 07, 2024 07:00 ET
|
Theriva Biologics, Inc.
- Reported topline data from the investigator sponsored Phase 1 trial of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma; trial results were determined to be positive by the...
CRCAM Alpes Provence : déclarations_hebdomadaires_CAAP_S18-2024
May 06, 2024 12:15 ET
|
CRCAM Alpes Provence
CAISSE REGIONALE DE CREDIT AGRICOLE MUTUEL ALPES PROVENCE Société coopérative à capital variable25, Chemin des trois cyprès 13097 Aix en Provence...
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
May 06, 2024 08:00 ET
|
PROCEPT BioRobotics
SAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
May 03, 2024 16:30 ET
|
Fate Therapeutics, Inc.
Off-the-shelf, CD19-targeted CAR NK Cell Product Candidate Drives Rapid and Deep Depletion of SLE Donor CD19+ B cells ADR Technology Incorporated into FT522 Induces Functional Persistence and...
XPO Reports First Quarter 2024 Results
May 03, 2024 06:45 ET
|
XPO, Inc.
GREENWICH, Conn., May 03, 2024 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO) today announced its financial results for the first quarter 2024. The company reported diluted earnings from continuing operations...
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
May 02, 2024 17:00 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...